Tag: low-income countries
Global Health Access: How Generics Are Changing Medicine in Low-Income Countries
Generics cut drug costs by up to 95%, yet millions in low-income countries still can't access them. Learn why affordable medicines aren't reaching those who need them most-and what’s being done to fix it.
view morerecent posts
Compare Atorlip 20 (atorvastatin) with other cholesterol meds like Lipitor, rosuvastatin, and ezetimibe. Learn which alternatives work better, cost less, and have fewer side effects - with real UK prescribing data.
Published ON: 18 NovYour gut bacteria can turn medications into toxins or make them useless. Learn how microbiome-drug interactions cause unexpected side effects and what’s being done to personalize treatment.
Published ON: 12 NovCultural beliefs about pill appearance, ingredients like gelatin, and trust in healthcare shape how patients use generic medications. Learn how religion, color, and misinformation affect adherence - and what patients and providers can do about it.
Published ON: 22 NovIntra-articular steroid injections offer quick pain relief but carry hidden risks like joint damage, bone loss, and systemic side effects. Learn who’s most at risk and what safer alternatives exist.
Published ON: 17 NovExplore how the EU's multi-track regulatory system for generic medicines affects drug availability, pricing, and competition across member states-with key updates from the 2025 Pharma Package reforms.
Published ON: 17 Nov